Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Weksler

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|November 30, 2000
Antiplatelet agents in stroke prevention. combination therapy: present and futureB B Weksler
Annals of the New York Academy of Sciences|January 1, 1987
Regulation of prostaglandin synthesis in human vascular cellsB B Weksler
Circulation|November 1, 1984
Prostaglandins and vascular functionB B Weksler
Alimentary Pharmacology & Therapeutics|December 6, 2007
Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver diseaseB B Weksler
Progress in Hemostasis and Thrombosis|January 1, 1982
ProstacyclinB B Weksler
Clinics in Laboratory Medicine|December 1, 1983
Platelets and the inflammatory responseB B Weksler
Current Opinion in Neurology|February 1, 1995
Hematologic disorders and ischemic strokeB B Weksler
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Regulation of cyclooxygenase activity in human vascular tissueB B Weksler
Journal of Cellular Physiology|March 1, 1990
Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both prostaglandin H synthase and prostacyclin synthaseB B Weksler
World Review of Nutrition and Dietetics|January 1, 1994
Omega 3 fatty acids have multiple antithrombotic effectsB B Weksler
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Cerebrovascular Diseases (Basel, Switzerland)|November 30, 2000
Antiplatelet agents in stroke prevention. combination therapy: present and futureB B Weksler
Annals of the New York Academy of Sciences|January 1, 1987
Regulation of prostaglandin synthesis in human vascular cellsB B Weksler
Circulation|November 1, 1984
Prostaglandins and vascular functionB B Weksler
Alimentary Pharmacology & Therapeutics|December 6, 2007
Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver diseaseB B Weksler
Progress in Hemostasis and Thrombosis|January 1, 1982
ProstacyclinB B Weksler
Clinics in Laboratory Medicine|December 1, 1983
Platelets and the inflammatory responseB B Weksler
Current Opinion in Neurology|February 1, 1995
Hematologic disorders and ischemic strokeB B Weksler
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Regulation of cyclooxygenase activity in human vascular tissueB B Weksler
Journal of Cellular Physiology|March 1, 1990
Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both prostaglandin H synthase and prostacyclin synthaseB B Weksler
World Review of Nutrition and Dietetics|January 1, 1994
Omega 3 fatty acids have multiple antithrombotic effectsB B Weksler
Pageof 11